Aktis Oncology, Inc.

AKTS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.0B · 79 employees
6
SEC Filings
$20.74
Close 2026-05-29
79
Employees

Business Summary

Aktis Oncology is a clinical-stage oncology company developing targeted radiopharmaceuticals using a proprietary miniprotein radioconjugate platform. Its lead candidate, [225Ac]Ac-AKY-1189, targets Nectin-4 and is in Phase 1b trials for locally advanced or metastatic urothelial cancer and other solid tumors. The company focuses on alpha-emitting radioisotopes, end-to-end supply chain development, and expanding radiopharmaceutical use beyond traditional nuclear medicine settings.

Latest Stock Quote

AKTS 2026-05-29 $20.74 O:$20.44 H:$21 L:$20.02 Vol:0.1M VWAP:$20.5943
origin leaf: c9f321f4652b927c50d24159482ac4edb7a31cb1058df84b8ccb50fac3042a51

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-131748EDGAR147K words

Quarterly Reports (10-Q)

No 10-Q filings indexed.

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-132524EDGAR1K words
2026-01-120001193125-26-010354EDGAR—

6 total filings indexed. 3 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology radiopharmaceuticals urothelial-cancer breast-cancer lung-cancer targeted-cancer-therapy cgmp-(current-good-manufacturing-practice) dota-chelation-chemistry ind-(investigational-new-drug)-regulatory-framework section-21-mrsa-(medicines-and-related-substances-act)

Company Identity

CIK0002035832
TickerAKTS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.aktisoncology.com
Listed2026-01-09

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: cb19c172c1e8c417ee3e79027f7ea2346c7a3856cb5cf83520e1a2bc4ae1d4bd
parent: e7419903a9f5f2982096dbbcdd4b9a08653e968da5d213d646f2a3b578de1bdb
content hash: e37848d32c69c16fcb006cb510b886f78e57c8f7807416927bcbaddc47ba8ca7
signed: 2026-06-02T19:00:08.697Z
sources: 2 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf